Balyasny Asset Management key facts
- Balyasny Asset Management is a hedge fund based in 303 Colorado Street, Suite 1900 with 8 tracked portfolio companies.
- Notable positions include Forterra, Diagonal Therapeutics, Solve Therapeutics.
- PrivateMarketView records 1 deal participation by Balyasny Asset Management.
- The team roster lists 23 people.
- Balyasny Asset Management reports $138.8B in regulatory assets under management across 38 private funds, per its SEC Form ADV (2026-03).
About Balyasny Asset Management
Founded in 2001, Balyasny Asset Management is a long/short equity hedge fund manager based in Austin, Texas. The firm employs a strategy in equities, macro, and commodities.
Investment focus
Its SEC Form ADV lists $139 billion in regulatory assets under management across 38 private funds (Mar 2026).
Investment activity
Balyasny Asset Management joined 1 recorded round in the last two years. 1 round landed in the last 90 days. Most recently: Expedition Therapeutics (Series B, Aug 2026).
Balyasny Asset Management portfolio at a glance
8 portfolio companies are on record for Balyasny Asset Management, including Forterra, Diagonal Therapeutics and Solve Therapeutics. The book leans Aerospace and Defense (2), Biotechnology (1) and Drug Discovery (1).
7 of the 8 carry a recorded valuation.
Balyasny Asset Management team
23 people are on record at Balyasny Asset Management: 20 partners, 1 managing partner, 1 principal and 1 associate. Senior names include Dmitry Balyasny (Co-Founder), Alexander Lurye (Partner) and Anita Nassar (Partner). 23 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Balyasny Asset Management at the SEC
Form ADV · 2026-03 · CRD 138111- Regulatory AUM
- $138.8B
- Private fund assets
- $277.6B
- Private funds
- 38 · 1 venture, 3 private equity, 34 hedge
- Staff
- 2434
- Registered office
- CHICAGO, IL
- SEC status
- Approved
Discloses a disciplinary history on Form ADV. Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as BALYASNY ASSET MANAGEMENT L.P.).
- ·The top 10 names in the book — of 8 recorded positions
- ·Watchlist + alerts for Balyasny Asset Management's activity
Portfolio
8 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Forterra | Aerospace and Defense | ▮ | ▮ | ▮ |
| Diagonal Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
| Solve Therapeutics | — | ▮ | ▮ | ▮ |
+ 5 more companies · all 8, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Balyasny Asset Management recent deals
1 recordedMembership and data by Private Market View
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Balyasny Asset Management
- What companies does Balyasny Asset Management invest in?
- Balyasny Asset Management has 8 recorded portfolio companies, including Forterra, Diagonal Therapeutics, Solve Therapeutics.
- What is Balyasny Asset Management's AUM?
- Balyasny Asset Management manages approximately $265.1B in assets.